Clinical impact of amyloid positron emission tomography - Is it worth the cost?

Richard J. Caselli; Bryan K. Woodruff

doi:10.1001/jamaneurol.2016.3792

Clinical impact of amyloid positron emission tomography - Is it worth the cost?

Richard J. Caselli, Bryan K. Woodruff

Neurology

Research output: Contribution to journal › Editorial › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	1396-1398
Number of pages	3
Journal	JAMA neurology
Volume	73
Issue number	12
DOIs	https://doi.org/10.1001/jamaneurol.2016.3792
State	Published - Dec 1 2016

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1001/jamaneurol.2016.3792

Cite this

@article{07979a7edb22420ab8711cfa5965fd3f,

title = "Clinical impact of amyloid positron emission tomography - Is it worth the cost?",

author = "Caselli, {Richard J.} and Woodruff, {Bryan K.}",

note = "Funding Information: National Institute on Aging grants AG19610 and AG031581 and the Arizona Alzheimer's Research Consortium",

year = "2016",

month = dec,

day = "1",

doi = "10.1001/jamaneurol.2016.3792",

language = "English (US)",

volume = "73",

pages = "1396--1398",

journal = "JAMA neurology",

issn = "2168-6149",